Cannabis Law Report

JUNE 6, 2022

TRC Healthcare (TRC) has launched a new training program to help pharmacists deliver better healthcare for patients who use cannabis products. Patients expect their pharmacists to know how cannabis interacts with their medications and conditions. Press Release.

Education 52

Education Research and Development Pharmaceutical Programs 52

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

NORML

JANUARY 11, 2019

Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. NH resident?

Legislation 191

Legislation Decriminalization Hemp Patients 191

MMJ Recs

JANUARY 6, 2024

In recent years, the landscape of medical marijuana has evolved dramatically, offering patients a diverse array of products tailored to address a myriad of health conditions. Inhalable options , including vaporizers and pre-rolled joints, allow for rapid onset of effects, making them suitable for conditions that require quick relief.

Chronic Pain 52

Chronic Pain Topical Marijuana Indica 52

Cannabis Law Report

JUNE 3, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

AUGUST 29, 2021

The export to Brazil also confirms the regulatory pathway and acts as a proof of concept in the largest market in South America where we aim to establish long-lasting supply relationships with our Brazilian pharmaceutical partners.”. 1 Source: Passport, Euromonitor International, Cannabis in Latin America, July 2021.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Cannabis Law Report

MARCH 1, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges such as regulatory compliance costs and market saturation may affect the profitability of cannabis businesses.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

OCTOBER 2, 2021

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

AUGUST 17, 2021

Technology licensing should be on the radar for pharmaceutical companies offering drugs for respiratory diseases. Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity. The Strategic Imperative. Cognita Labs.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

MAY 9, 2022

The company is following in the footsteps of GW Pharmaceuticals, a trailblazer that developed the first cannabis-based medicine to be licensed in the UK in 2010, Sativex for multiple sclerosis, which costs about £2,000 a year. However, NHS prescribing of the mouth spray remains very limited and varies across the country.

Chronic Pain 52

Chronic Pain Epilepsy Oil Pharmaceutical 52

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

JULY 29, 2021

With Avicanna’s dedication to quality standards and pharmaceutical positioning we are poised to be a significant long-term player in the European medical market that is predominantly focused on medical utility of cannabinoids and where meeting EU pharmacopeia standards are essential.”.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low. Product Split.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

NORML

JANUARY 25, 2019

Opioid dependency was added to New Jersey’s list of conditions for medical cannabis eligibility. And a North Dakota bill to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes was defeated in a Senate committee this week. FL resident? HI resident? IA resident?

Legislation 149

Legislation Patients Oil Hemp 149

Cannabis Law Report

MARCH 25, 2020

Panaxia aims to produce within a short period of time an inventory large enough to satisfy several months of demand of all Israeli patients requiring this care. Dadi Segal , Panaxia CEO: “We are pleased to be able to extend care to our patients in Israeli who are in acute need of this kind of medicinal cannabis care.

Oil 45

Oil Pharmaceutical Epilepsy Extraction 45

Cannabis Law Report

NOVEMBER 19, 2021

We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Position Requirements.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

FEBRUARY 15, 2019

Under strict manufacturing and pharmaceutical standards, 400 grammes of Bedrocan cannabis and 400 grammes of Bedica grown by Dutch biopharmaceutical firm, Bedrocan, was imported by IPS Specials following prescriptions issued for chronic pain at a cost of £695 per private patient. (In It has 15 wholly owned subsidiary companies.

History 56

History Legalization Chronic Pain Pharmaceutical 56

Cannabis Law Report

DECEMBER 14, 2019

Prohibition Partners’ has also estimated that up to 1 per-cent of the UK population could qualify as medical cannabis patients by 2028. Initially, Farmako Limited will pursue the import of Bedrocan products from the Netherlands to the UK for end patient distribution. VANCOUVER, British Columbia, Dec.

Pharmaceutical 59

Pharmaceutical Chronic Pain Patients Epilepsy 59

Cannabis Law Report

JUNE 19, 2021

Rules Based On Patient Benefit. Better inter-governmental co-operation must be beneficial as long as those involved understand that cannabis is a plant and not a pharmaceutical product.”. Grow Our Own”. This can only help the development of a thriving cannabis industry with consequent job creation and government tax income.

Research and Development 105

Research and Development Cannabinoids Medicine Hemp 105

Cannabis Law Report

SEPTEMBER 14, 2022

The cannabis-based treatment, Sativex, will now be available via NHS prescription in Scotland, to treat spasticity in MS patients. Although a limited number of people have been able to access it via the Peer Approved Clinical System (PACS) Tier 2 individual patient treatment request process.

Treatment 52

Treatment Access Patients Medicine 52

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I Mara: I got in as a, a patient both for myself and for my husband.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

FEBRUARY 25, 2019

A new legislative framework was also adopted by MPs, regulating cultivation, production, import and export of pharmaceutical cannabis and its use for in medical research, production of pharmaceuticals and the free prescription of pharmaceutical cannabis to eligible patients. Quite the contrary we are all for it.

Medicine 63

Medicine Law Research and Development Pharmaceutical 63

NORML

FEBRUARY 8, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. Legislation is pending, Proposed Bill 350, to limit patients who use medical cannabis in compliance with state law from seeking civil actions if they are discriminated against by their employer.

Legislation 172

Legislation Decriminalization Patients Access 172

Cannabis Law Report

JANUARY 19, 2022

Psygen also provided Health Canada with consent to be identified on a public list as a licensed dealer able to provide GMP psilocybin for use in patients through Canada’s special access program (the “ SAP “). “A primary application for psychedelics is to support psychotherapy for treatment of mental health conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Cannabis Law Report

OCTOBER 26, 2019

ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). The institution at which the trial will be conducted gives the final approval.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. authorizes home delivery to patients. authorizes home delivery to patients. Ability to meet the overall health needs of qualified patients and safety of the public.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JUNE 26, 2019

First and foremost, I’ll highlight the patient perspective, patients like myself who are legally registered State of Florida Medical Marijuana active ID cardholders. I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. authorizes home delivery to patients. authorizes home delivery to patients. Ability to meet the overall health needs of qualified patients and safety of the public.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . In light of all this state cannabis information overload, what are some of the reasons a patient ultimately chooses a qualified personal cannabis physician? .

Marijuana 45

Marijuana Patients Research and Development Programs 45

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Well, partners, of course on the cannabis enigma, yeah, let’s listen to Nikki.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

SEPTEMBER 28, 2019

Access for patients: Czech Republic confirms medical cannabis subsidies. On Tuesday the proposal passed through parliament – meaning that from the new year patients will be paying just hundreds a month for their medical cannabis rather than the thousands they will currently be paying. Czech Republic.

Epilepsy 40

Epilepsy Chronic Pain Medicine Pharmaceutical 40

Cannabis Law Report

JULY 30, 2019

On the pressing question of using cannabis as medicine in the various delivery routes available to Florida patients, Dr. Moltke weighs in again at Get The Dose : . Florida’s currently updated Patients OMMU Registry provides more detailed information on medical marijuana. “ Confused? as proof of residency.

Marijuana 40

Marijuana Patients Edibles Programs 40

Puff Puff Post

APRIL 2, 2020

Through their (Supreme’s) subsidiary, Truverra , they partnered with Israeli pharmaceutical company, Breath of Life International Ltd. Supreme Cannabis is a partner that shares our high standards for quality and respect for patients and consumers,” said Dr. Tamir Gedo, CEO of BOL Pharma. BOL Pharma).

Medicine 52

Medicine Research and Development Events Cannabis 52

Puff Puff Post

APRIL 2, 2020

Through their (Supreme’s) subsidiary, Truverra , they partnered with Israeli pharmaceutical company, Breath of Life International Ltd. Supreme Cannabis is a partner that shares our high standards for quality and respect for patients and consumers,” said Dr. Tamir Gedo, CEO of BOL Pharma. BOL Pharma).

Medicine 52

Medicine Research and Development Events Cannabis 52

Canna Law Blog

NOVEMBER 16, 2021

As to the permit itself, there are conditions on its receipt. In the event a Tribe or State doesn’t develop a plan or the plan is rejected by USDA, then growers will just follow the overall system put together by USDA (these directives are very similar to the standards set out in the 2018 Farm Bill, legalizing hemp).

DEA 88

DEA Business Banking Food 88